Accessibility Menu
 
ResMed logo

ResMed

(ASX) RMD

Current Price$29.78
Market Cap$44.21B
Since IPO (1999)+4,109%
5 Year+19%
1 Year-18%
1 Month-7%

ResMed Financials at a Glance

Market Cap

$44.21B

Revenue (TTM)

$5.42B

Net Income (TTM)

$1.49B

EPS (TTM)

$1.57

P/E Ratio

19.34

Dividend

$0.35

Beta (Volatility)

-0.02 (Low)

Price

$29.78

Volume

1,991,023

Open

$29.11

Previous Close

$29.78

Daily Range

$28.89 - $29.90

52-Week Range

$28.89 - $45.25

RMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ResMed

Industry

Healthcare Equipment and Supplies

Employees

10,600

CEO

Mick Farrell, MBA

Headquarters

San Diego, CA 92123, US

RMD Financials

Key Financial Metrics (TTM)

Gross Margin

61%

Operating Margin

34%

Net Income Margin

28%

Return on Equity

26%

Return on Capital

25%

Return on Assets

17%

Earnings Yield

5.17%

Dividend Yield

1.16%

Payout Ratio

22.25%

Stock Overview

Market Cap

$44.21B

Shares Outstanding

1.46B

Volume

1.99M

Avg. Volume

1.31M

Financials (TTM)

Gross Profit

$3.05B

Operating Income

$1.69B

EBITDA

$1.92B

Operating Cash Flow

$1.75B

Capital Expenditure

$100.64M

Free Cash Flow

$1.65B

Cash & ST Invst.

$1.21B

Total Debt

$851.81M

ResMed Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.45B

+12.8%

Gross Profit

$881.28M

+17.3%

Gross Margin

60.93%

N/A

Market Cap

$44.21B

N/A

Market Cap/Employee

$4.43M

N/A

Employees

9,980

N/A

Net Income

$399.08M

+15.8%

EBITDA

$567.70M

+56.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$424.83M

+233.7%

Accounts Receivable

$1.05B

+21.8%

Inventory

$922.67M

+4.6%

Long Term Debt

$712.67M

-11.1%

Short Term Debt

$289.86M

+668.5%

Return on Assets

17.47%

N/A

Return on Invested Capital

25.15%

N/A

Free Cash Flow

$317.87M

+9.7%

Operating Cash Flow

$347.02M

+12.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SIG.AXSigma Healthcare Limited
$2.79+0.36%
CSL.AXCSL Limited
$124.37-1.12%
FPH.AXFisher & Paykel Healthcare Corporation Limited
$29.82+0.95%
SHL.AXSonic Healthcare Limited
$19.77-0.80%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$12.54+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.59+0.09%
SOFISoFi Technologies
$16.17+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.36+0.04%

Questions About RMD

What is the current price of ResMed?

ResMed is trading at A$29.78 per share.

What is the 52-week range for ResMed?

Over the past 52 weeks, ResMed has traded between A$28.89 and A$45.25.

How much debt does ResMed have?

As of the most recent reporting period, ResMed reported total debt of $1.27B.

How much cash does ResMed have on hand?

ResMed reported $2.13B in cash and cash equivalents in its most recent financial results.

What is ResMed’s dividend yield?

ResMed currently has a dividend yield of 1.16%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.